News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

DoD FY25 Melanoma Research Program Focused Program Award – Rare Melanomas
Jun 28, 2025, 22:16

DoD FY25 Melanoma Research Program Focused Program Award – Rare Melanomas

Supports a multidisciplinary research program of 2–3 complementary projects addressing a unifying question in rare melanoma (e.g., uveal, mucosal, acral) biology, prevention, diagnosis, treatment, or survivorship. Awards fund high-impact, synergistic efforts from discovery through clinical translation, including clinical trials when appropriate. 

Eligibility Criteria:

  • Applicant Organizations: Extramural and intramural U.S. or foreign academic institutions, biotech companies, foundations, DOD laboratories, and other public or private entities (for-profit and non-profit). 

  • Principal Investigators:

    • Initiating PI: Independent investigator at ≥ Associate Professor level (or equivalent) dedicating ≥ 10% effort.

    • Partnering PI(s): Independent investigators at ≥ Assistant Professor level (or equivalent).

  • Team Composition: 2–3 PIs, each leading one project; consumer/collaborator engagement strongly encouraged.

  • Scope: At least two distinct but synergistic research projects; may include preclinical studies, translational work, and clinical trials (with requisite preliminary data).

  • Cost Sharing: Not required; awards made to organizations.

Funding Details:

  • Total Pool: ≈ $5.6 M to fund ~2 awards

  • Award Cap: Combined total costs ≤ $2.8 M per award over up to 4 years

  • Allowable Costs: Direct and indirect costs per negotiated rate; personnel, supplies, equipment, travel (including milestone meeting), data sharing infrastructure; no tuition.

  • Payments: Quarterly in U.S. currency to each PI’s institution. 

Deadlines:

  • Pre-Application (Preproposal): June 30, 2025 by 5 p.m. ET

  • Invitation to Submit Full Application: July 31, 2025

  • Full Application: October 1, 2025 by 11:59 p.m. ET

  • Verification Period Ends: October 7, 2025 by 5 p.m. ET

  • Peer Review: December 2025

  • Programmatic Review: February 2026 

Where to Go for Further Information & Application:

cancer CDMRP clinical trials consumer engagement Data Sharing DoD focused-program-award Melanoma multidisciplinary-research OncoDaily Oncology rare-melanomas translational research
Special Coverage
Blog
Jun 29, 2025, 05:02
Giselle Sholler Congratulates Interns for Presenting Pediatric Cancer Research at Penn State Health
Drugs
Jun 29, 2025, 04:56
Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Blog
Jun 29, 2025, 04:54
Valerie Yang Recognizes NUS Students for Research on Mucosal Melanoma and Psychological Outcomes in Rare Cancers
Blog
Jun 29, 2025, 04:37
Tricia Hernandez: How Do You Survive Cancer?
Blog
Jun 29, 2025, 04:28
Lung Cancer Europe - Can Laughter Really Help When You're Living with Lung Cancer?
Blog
Jun 29, 2025, 01:56
Pramesh CS: Last Chance to Apply for Cancer research methods workshop (CReDO)
Insight
Jun 28, 2025, 21:37
Stephen V Liu: Navigating Selective Dose Intensification in EGFR-Variant Non–Small Cell Lung Cancer
Blog
Jun 28, 2025, 20:35
Vincent Rajkumar: Mark Cuban Cost Plus Drug Company Shows True Leadership in Lowering Prescription Drug Costs
Blog
Jun 28, 2025, 19:09
Mark Lawler: Highlighting the Economic Losses Due to Cancer Mortality in the UK
Blog
Jun 28, 2025, 18:19
Fumiko Ladd Chino: Dr Lauren Ghazal Gave an Important Talk at MASCC25 on Financial Toxicity in AYA Cancer
Oncolibrary
Jun 28, 2025, 17:42
MASCC 2025 Highlights: Gut Microbiota as a Novel Target for Managing Chemotherapy-Induced Neurological Toxicities
Blog
Jun 28, 2025, 17:34
Angela Mastronuzzi Reflects on Return to Her Alma Mater for "Ludovico Necchi" Association Meeting